COUGHLIN CHRISTOPHER J — SEC insider filings
SEC reporting owner CIK 1110750. 38 insider filings on record with FilingPulse; latest filed 2026-09-30.
Transaction summary — filings shown
Covers all 38 filings on record, filed 2020-08-06 to 2026-09-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 22,000 shares, $1,570,840 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 878 shares, $67,382 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 49.
- Largest priced transaction: purchase of 12,000 shares @ $81.37 ($976,440) in CENTENE CORP, filed 2022-05-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CENTENE CORP (CNC) | Director | 28 | 2 legs · 22,000 sh · $1,570,840 | 1 leg · 878 sh · $67,382 | 26 |
| Karuna Therapeutics, Inc. (KRTX) | Director | 5 | — | — | 14 |
| ALEXION PHARMACEUTICALS, INC. (ALXN) | Director | 2 | — | — | 6 |
| Prestige Consumer Healthcare Inc. (PBH) | Director | 3 | — | — | 3 |
Insider filings — COUGHLIN CHRISTOPHER J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-30 | 4 | CENTENE CORP (CNC) | Grant/award (A): 583 @ $0 | EDGAR |
| 2026-07-01 | 4 | CENTENE CORP (CNC) | Grant/award (A): 562 @ $0 | EDGAR |
| 2026-05-13 | 4 | CENTENE CORP (CNC) | Grant/award (A): 3,992 @ $0 | EDGAR |
| 2026-03-31 | 4 | CENTENE CORP (CNC) | Grant/award (A): 1,140 @ $0 | EDGAR |
| 2026-01-05 | 4 | CENTENE CORP (CNC) | Grant/award (A): 729 @ $0 | EDGAR |
| 2025-10-01 | 4 | CENTENE CORP (CNC) | Grant/award (A): 852 @ $0 | EDGAR |
| 2025-07-02 | 4 | CENTENE CORP (CNC) | Grant/award (A): 556 @ $0 | EDGAR |
| 2025-05-14 | 4 | CENTENE CORP (CNC) | Grant/award (A): 3,579 @ $0 | EDGAR |
| 2025-04-02 | 4 | CENTENE CORP (CNC) | Grant/award (A): 500 @ $0 | EDGAR |
| 2025-01-03 | 4 | CENTENE CORP (CNC) | Grant/award (A): 497 @ $0 | EDGAR |
| 2024-12-17 | 4 | CENTENE CORP (CNC) | Purchase (P): 10,000 @ $59.44 | EDGAR |
| 2024-10-02 | 4 | CENTENE CORP (CNC) | Grant/award (A): 402 @ $0 | EDGAR |
| 2024-07-02 | 4 | CENTENE CORP (CNC) | Grant/award (A): 452 @ $0 | EDGAR |
| 2024-05-24 | 4 | CENTENE CORP (CNC) | Sale (S): 878 @ $76.75 | EDGAR |
| 2024-05-16 | 4 | CENTENE CORP (CNC) | Grant/award (A): 2,916 @ $0 | EDGAR |
| 2024-04-02 | 4 | CENTENE CORP (CNC) | Grant/award (A): 388.55 @ $0 | EDGAR |
| 2024-03-18 | 4 | Karuna Therapeutics, Inc. (KRTX) | Disposition to issuer (D): 990 @ $330 · Disposition to issuer (D): 25,000 (derivative) @ $243.35 · Disposition to issuer (D): 8,500 (derivative) @ $201.99 · Disposition to issuer (D): 5,000 (derivative) @ $227.04 · Disposition to issuer (D): 976 (derivative) @ $136.81 · Disposition to issuer (D): 1,904 (derivative) @ $92.30 | EDGAR |
| 2024-01-03 | 4 | CENTENE CORP (CNC) | Grant/award (A): 502.50 @ $0 | EDGAR |
| 2023-10-03 | 4 | CENTENE CORP (CNC) | Grant/award (A): 544.87 @ $0 | EDGAR |
| 2023-07-05 | 4 | CENTENE CORP (CNC) | Grant/award (A): 543.56 @ $0 | EDGAR |
| 2023-06-22 | 4 | Karuna Therapeutics, Inc. (KRTX) | Grant/award (A): 990 @ $0 · Grant/award (A): 1,904 (derivative) @ $0 | EDGAR |
| 2023-05-12 | 4 | CENTENE CORP (CNC) | Grant/award (A): 2,947 @ $0 | EDGAR |
| 2023-04-04 | 4 | CENTENE CORP (CNC) | Grant/award (A): 510.63 @ $0 | EDGAR |
| 2023-01-05 | 4 | Karuna Therapeutics, Inc. (KRTX) | Grant/award (A): 321 (derivative) @ $110.41 · Grant/award (A): 407 (derivative) @ $110.57 · Grant/award (A): 67 (derivative) @ $111.94 · Grant/award (A): 181 (derivative) @ $110.50 | EDGAR |
| 2023-01-04 | 4 | CENTENE CORP (CNC) | Grant/award (A): 443.81 @ $0 | EDGAR |
| 2022-10-04 | 4 | CENTENE CORP (CNC) | Grant/award (A): 405.62 @ $0 | EDGAR |
| 2022-08-03 | 4 | Prestige Consumer Healthcare Inc. (PBH) | Grant/award (A): 2,495 @ $0 | EDGAR |
| 2022-07-05 | 4 | CENTENE CORP (CNC) | Grant/award (A): 436.43 @ $0 | EDGAR |
| 2022-06-16 | 4 | Karuna Therapeutics, Inc. (KRTX) | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2022-05-03 | 4 | CENTENE CORP (CNC) | Purchase (P): 12,000 @ $81.37 | EDGAR |
| 2022-04-28 | 4 | CENTENE CORP (CNC) | Grant/award (A): 2,323 @ $0 | EDGAR |
| 2022-04-04 | 4 | CENTENE CORP (CNC) | Grant/award (A): 441.96 @ $82.02 | EDGAR |
| 2022-02-09 | 4 | CENTENE CORP (CNC) | Grant/award (A): 1,100 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2021-08-05 | 4 | Prestige Consumer Healthcare Inc. (PBH) | Grant/award (A): 2,808 @ $0 | EDGAR |
| 2021-07-23 | 4 | ALEXION PHARMACEUTICALS, INC. (ALXN) | Disposition to issuer (D): 42,347 @ $0 · Disposition to issuer (D): 2,294 (derivative) @ $138.86 · Disposition to issuer (D): 2,706 (derivative) @ $167.97 · Disposition to issuer (D): 2,343 (derivative) @ $155.01 | EDGAR |
| 2021-06-23 | 4 | Karuna Therapeutics, Inc. (KRTX) | Grant/award (A): 8,500 (derivative) @ $0 | EDGAR |
| 2021-05-24 | 4 | ALEXION PHARMACEUTICALS, INC. (ALXN) | Grant/award (A): 1,962 @ $0 · Grant/award (A): 729 @ $0 | EDGAR |
| 2020-08-06 | 4 | Prestige Consumer Healthcare Inc. (PBH) | Grant/award (A): 3,732 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1110750 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs